Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
And some say that if the current situation continues ... proposed under the previous administration’s FDA, says Steven Mandernach, executive director of the Association of Food and Drug ...
And some say that if the current situation continues ... proposed under the previous administration’s FDA, says Steven Mandernach, executive director of the Association of Food and Drug ...
The move comes after hospitalizations and deaths from foodborne illnesses more than doubled last year in the US.
The Trump administration’s moves to shrink the federal workforce put the FDA’s ability to regulate drugs and oversee the ...
But during a committee hearing with the Food and Drug Administration’s (FDA) director nominee ... the issue lies with her, not the current administration. Her inconsistent responses reveal ...
FDA reviewers of Elon Musk's Neuralink among those fired Current and former FDA officials ... including a stint as acting director of the office that reviews human-trial requests for brain implants.
Jayanta (Jay) Bhattacharya, nominated to be Director of the National Institutes ... maintaining the approval of mifepristone or the current FDA-required Risk Evaluation and Mitigation Strategies ...
And some say that if the current situation continues ... going into effect were first proposed under the previous administration’s FDA, says Steven Mandernach, executive director of the Association of ...
Mitch Zeller, former FDA director for tobacco ... and many of the agency's current inspectors are recent hires. It was not immediately clear whether those employees were exempted.
Mitch Zeller, former FDA director for tobacco ... and many of the agency’s current inspectors are recent hires. It was not immediately clear whether those employees were exempted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results